These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 37679492

  • 1. Demographics and treatment of patients with primary nephrotic syndrome in Japan using a national registry of clinical personal records.
    Nakagawa N, Kimura T, Sakate R, Wada T, Furuichi K, Okada H, Isaka Y, Narita I.
    Sci Rep; 2023 Sep 07; 13(1):14771. PubMed ID: 37679492
    [Abstract] [Full Text] [Related]

  • 2. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H, Sugiyama H, Narita I, Saito T, Yamagata K, Nishio S, Fujimoto S, Mori N, Yuzawa Y, Okuda S, Maruyama S, Sato H, Ueda Y, Makino H, Matsuo S.
    Clin Exp Nephrol; 2015 Jun 07; 19(3):496-505. PubMed ID: 25230687
    [Abstract] [Full Text] [Related]

  • 3. Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.
    Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.
    Clin Exp Nephrol; 2018 Dec 07; 22(6):1266-1280. PubMed ID: 29679356
    [Abstract] [Full Text] [Related]

  • 4. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
    Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.
    Clin Exp Nephrol; 2020 Jun 07; 24(6):526-540. PubMed ID: 32146646
    [Abstract] [Full Text] [Related]

  • 5. Clinical manifestations of focal segmental glomerulosclerosis in Japan from the Japan Renal Biopsy Registry: age stratification and comparison with minimal change disease.
    Ozeki T, Maruyama S, Imasawa T, Kawaguchi T, Kitamura H, Kadomura M, Katafuchi R, Oka K, Yokoyama H, Sugiyama H, Sato H.
    Sci Rep; 2021 Jan 28; 11(1):2602. PubMed ID: 33510182
    [Abstract] [Full Text] [Related]

  • 6. Demographics and treatment of patients with primary membranoproliferative glomerulonephritis in Japan using a national registry of clinical personal records.
    Nakagawa N, Kimura T, Sakate R, Isaka Y, Narita I.
    Clin Exp Nephrol; 2023 Nov 28; 27(11):928-935. PubMed ID: 37515698
    [Abstract] [Full Text] [Related]

  • 7. Population-based identification and temporal trend of children with primary nephrotic syndrome: The Kaiser Permanente nephrotic syndrome study.
    Parikh RV, Tan TC, Fan D, Law D, Salyer AS, Yankulin L, Wojcicki JM, Zheng S, Ordonez JD, Chertow GM, Khoshniat-Rad F, Yang J, Go AS.
    PLoS One; 2021 Nov 28; 16(10):e0257674. PubMed ID: 34648518
    [Abstract] [Full Text] [Related]

  • 8. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
    Alshami A, Roshan A, Catapang M, Jöbsis JJ, Kwok T, Polderman N, Sibley J, Sibley M, Mammen C, Matsell DG, Pediatric Nephrology Clinical Pathway Development Team.
    Pediatr Nephrol; 2017 Oct 28; 32(10):1897-1905. PubMed ID: 28540445
    [Abstract] [Full Text] [Related]

  • 9. Increasing incidence of focal segmental glomerulosclerosis and an examination of demographic patterns.
    Dragovic D, Rosenstock JL, Wahl SJ, Panagopoulos G, DeVita MV, Michelis MF.
    Clin Nephrol; 2005 Jan 28; 63(1):1-7. PubMed ID: 15678691
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Adult primary nephrotic syndrome trends by race: a diminished frequency of focal segmental glomerulosclerosis in non-black patients.
    Mbakop C, DeVita MV, Wahl SJ, Bijol V, Rosenstock JL.
    Int Urol Nephrol; 2021 Apr 28; 53(4):719-724. PubMed ID: 33200335
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.
    Bomback AS, Canetta PA, Beck LH, Ayalon R, Radhakrishnan J, Appel GB.
    Am J Nephrol; 2012 Apr 28; 36(1):58-67. PubMed ID: 22722778
    [Abstract] [Full Text] [Related]

  • 14. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis.
    Siligato R, Cernaro V, Nardi C, De Gregorio F, Gembillo G, Costantino G, Conti G, Buemi M, Santoro D.
    Expert Opin Investig Drugs; 2018 Nov 28; 27(11):839-879. PubMed ID: 30360670
    [Abstract] [Full Text] [Related]

  • 15. Is there really an increase in non-minimal change nephrotic syndrome in children?
    Filler G, Young E, Geier P, Carpenter B, Drukker A, Feber J.
    Am J Kidney Dis; 2003 Dec 28; 42(6):1107-13. PubMed ID: 14655180
    [Abstract] [Full Text] [Related]

  • 16. Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment.
    Hommos MS, Zeng C, Liu Z, Troost JP, Rosenberg AZ, Palmer M, Kremers WK, Cornell LD, Fervenza FC, Barisoni L, Rule AD.
    Kidney Int; 2018 May 28; 93(5):1175-1182. PubMed ID: 29273332
    [Abstract] [Full Text] [Related]

  • 17. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ.
    Clin Nephrol; 1995 Jun 28; 43(6):375-81. PubMed ID: 7554521
    [Abstract] [Full Text] [Related]

  • 18. Baseline characteristics and long-term outcomes of steroid-resistant nephrotic syndrome in children: impact of initial kidney histology.
    Watanabe Y, Fujinaga S, Endo A, Endo S, Nakagawa M, Sakuraya K.
    Pediatr Nephrol; 2020 Dec 28; 35(12):2377-2381. PubMed ID: 32964318
    [Abstract] [Full Text] [Related]

  • 19. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings.
    Pelletier JH, Kumar KR, Engen R, Bensimhon A, Varner JD, Rheault MN, Srivastava T, Straatmann C, Silva C, Davis TK, Wenderfer SE, Gibson K, Selewski D, Barcia J, Weng P, Licht C, Jawa N, Kallash M, Foreman JW, Wigfall DR, Chua AN, Chambers E, Hornik CP, Brewer ED, Nagaraj SK, Greenbaum LA, Gbadegesin RA.
    Pediatr Nephrol; 2018 Oct 28; 33(10):1773-1780. PubMed ID: 29982878
    [Abstract] [Full Text] [Related]

  • 20. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
    Madan A, Mijovic-Das S, Stankovic A, Teehan G, Milward AS, Khastgir A.
    BMC Nephrol; 2016 Mar 31; 17():37. PubMed ID: 27036111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.